Table 1:
Characteristics of included sets of screening principles
| Author(s), year of publication | No. of principles | Categorization of principles (if applicable) |
|---|---|---|
| Wilson and Jungner, 19681 | 10 | NA |
| Cochrane and Holland, 197112 | 7 | NA |
| Whitby, 197413 | 8 | NA |
| Cuckle and Wald, 198414 | 8 | NA |
| Hakama et al., 198515 | 8 | NA |
| Sackett et al., 198516 | 6 | NA |
| Prorok and Connor, 198617 | 9 | NA |
| Health Council of the Netherlands, 199418 | 21* | NA |
| Braveman and Tarimo, 199619 | 5 | NA |
| Clark and Reintgen, 199620 | 10 | (1) Characteristics of the disease, (2) Characteristics of the screening test |
| Parsonnet and Axon, 199621 | 6 | NA |
| Fowler and Austoker, 199722 | 9 | NA |
| Gray, 199723 | 5 | NA |
| Seymour et al., 199724 | 7 | NA |
| Schoemaker, 199825 | 10 | (1) Requirements for a suitable disease, (2) Requirements for a suitable screening procedure, (3) Requirements for a suitable treatment |
| UK National Screening Committee, 199826 | 17 | (1) Condition, (2) Test, (3) Treatment, (4) Screening program |
| Nielsen and Lang, 199927 | 6 | NA |
| Prorok et al., 199928 | 9 | NA |
| American Academy of Pediatrics Newborn Screening Taskforce, 200029 | 13* | NA |
| UK National Screening Committee, 200030 | 20* | (1) Condition, (2) Test, (3) Treatment, (4) Screening program |
| Katz, 200131 | 13 | (1) Disease specific, (2) Test specific, (3) Society or system specific |
| Hanselaar, 200232 | 14 | NA |
| National Committee on Colorectal Cancer Screening (Canada), 200233 | 9 | NA |
| New Zealand National Health Committee, 200334 | 8 | NA |
| UK National Screening Committee, 200335 | 23* | (1) Condition, (2) Test, (3) Treatment, (4) Screening program |
| Harris and Kinsinger, 200536 | 8 | NA |
| Miller, 200537 | 6* | NA |
| Strong et al., 200538 | 9 | NA |
| Andermann et al., 200839 | 10 | NA |
| Bryant and Hamdy, 200840 | 9 | NA |
| Lewis et al., 200841 | 20 | (1) Disease, (2) Diagnostic test, (3) Diagnosis and treatment, (4) Overall screening program |
| Mandel and Smith, 200842 | 12 | NA |
| Andermann et al., 201143 | 20 | (1) Laboratory testing level, (2) Clinical services level, (3) Program management level |
| Grootendorst et al., 200944 | 20 | (1) Condition, (2) Treatment, (3) Test used in screening, (4) Cost, (5) Screening program |
| Harris et al., 201145 | 7 | NA |
| Martin-Moreno et al., 201246 | 8 | Each principle described under 4 elements: (1) Governance, (2) Financing, (3) Resource generation, (4) Service delivery |
| Petros, 201247 | 21 | NA |
| Adriaensen et al., 201348 | 7 | (1) Technical accuracy, (2) Clinical pathway, (3) Diagnostic accuracy, (4) Longitudinal clinical sensitivity, (5) Impact on a patient level, (6) Impact on a population level and cost-effectiveness |
| Forman et al., 201349 | 14 | NA |
| Lewis et al., 201450 | 18 | (1) Disease, (2) Diagnostic test, (3) Diagnosis and treatment, (4) Overall screening program |
| UK National Screening Committee, 201551 | 20 | (1) Condition, (2) Test, (3) Intervention, (4) Screening program, (5) Implementation criteria |
Note: NA = not applicable.
*
Total number of principles includes subprinciples.